Alnylam Pharmaceuticals | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2025-03
Agios Pharmaceuticals USD 74K 1000 2025-03
Alnylam Pharmaceuticals USD 1.3M 10K 2025-03
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 230K 12K 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Incyte USD 193K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Moderna USD 38.7K 100 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
PTC Therapeutics USD 78K 1000 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Takeda JPY 1.69T 25M 2025-03
Tectonic Therapeutic USD 2K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Xencor USD 712K 9K 2025-03



Alnylam Pharmaceuticals Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.